Cochlear Limited (ASX:COH)

Market Cap	19.69B
Revenue (ttm)	2.34B
Net Income (ttm)	388.90M
Shares Out	65.40M
EPS (ttm)	5.93
PE Ratio	50.78
Forward PE	43.57
Dividend	4.30 (1.42%)
Ex-Dividend Date	Sep 18, 2025

Volume	110,620
Average Volume	166,082
Open	297.95
Previous Close	301.01
Day's Range	297.95 - 303.70
52-Week Range	246.14 - 323.00
Beta	0.40
RSI	43.57
Earnings Date	Aug 15, 2025

About Cochlear

Cochlear Limited provides implantable hearing solutions for children and adults worldwide. The company offers cochlear implant systems, sound processor upgrades, bone conduction systems, and other products. It also provides cochlear nucleus systems, including Nucleus sound processors, smart bimodal hearing solution, and Nucleus implants; cochlear Baha systems comprising Baha 6 max sound processor and Baha implant; and accessories, such as wireless devices and Nucleus water-safe accessories. The company was founded in 1981 and is headquartered i...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1981
• Employees: 5,500
• Stock Exchange: Australian Securities Exchange
• Ticker Symbol: COH

Financial Performance

In 2025, Cochlear's revenue was 2.34 billion, an increase of 4.81% compared to the previous year's 2.24 billion. Earnings were 388.90 million, an increase of 9.00%.